|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7660 EUR | -0.52% |
|
-3.04% | -20.21% |
| 05-22 | Transgene SA Announces Board Appointments | CI |
| 04-13 | Transgene Completes Patient Randomization in Phase 2 Clinical Trial Evaluating TG4050 in Adjuvant Treatment of Head and Neck Cancer | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.52% | -3.04% | -2.67% | -1.79% | -20.21% | -20.21% | -61.70% | -73.68% | -71.73% | 243M | |
| +0.70% | +2.11% | +12.03% | +26.98% | +9.12% | +54.65% | +111.41% | +196.96% | +6,840.55% | 55.58B | |
| +0.03% | +0.33% | -10.72% | +4.50% | +7.09% | +49.22% | +43.94% | -33.52% | - | 43.47B | |
| +3.93% | -0.06% | -4.07% | -1.43% | -5.95% | -15.10% | -18.04% | -62.46% | - | 22.64B | |
| +5.27% | -7.82% | -6.90% | -30.62% | -44.43% | -1.29% | +388.48% | +221.76% | +788.97% | 20.96B | |
| +3.81% | -5.07% | -7.77% | -11.50% | -1.15% | +12.00% | -29.52% | -74.31% | - | 15.79B | |
| +0.51% | +0.96% | -5.02% | -6.55% | -19.76% | +9.60% | -39.76% | -39.83% | +43.81% | 15.3B | |
| +1.75% | +1.92% | +7.62% | +28.14% | +22.06% | +29.13% | +178.65% | +132.81% | +624.93% | 13.45B | |
| +5.27% | +5.54% | -9.90% | +7.01% | +5.86% | +14.25% | - | - | - | 11.74B | |
| -5.27% | -0.43% | +32.29% | +39.40% | +98.72% | +87.77% | +208.02% | +1,016.91% | +413.14% | 10.96B | |
| +0.63% | -3.76% | -4.58% | +9.91% | -18.56% | +61.13% | +78.62% | +339.39% | - | 10.93B | |
| +4.78% | -1.71% | -29.23% | -17.19% | -18.58% | -3.61% | +164.75% | +49.84% | - | 10.32B | |
| +0.23% | -11.86% | -29.90% | -18.66% | -25.21% | -33.20% | +647.43% | +91.79% | +39.15% | 10.15B | |
| +5.20% | -1.00% | -4.28% | +28.07% | +12.08% | +344.50% | +110.67% | -16.12% | +1,171.97% | 10.48B | |
| +0.08% | +31.30% | +18.08% | +23.39% | +22.73% | +60.51% | +195.19% | - | - | 9.75B | |
| +3.28% | -4.18% | -7.09% | +8.86% | +9.02% | +109.21% | +87.06% | +229.23% | +743.73% | 9.4B | |
| +3.15% | -1.23% | -11.22% | -12.94% | +263.64% | +122.22% | +153.52% | -52.60% | - | 7.54B | |
| +7.04% | +5.74% | -21.44% | -13.52% | +3.54% | +29.31% | +133.70% | -39.19% | - | 7.34B | |
| +1.00% | +1.92% | +4.41% | +7.14% | +6.68% | +19.29% | +75.74% | +1.98% | +251.51% | 7.03B | |
| +3.58% | -4.93% | -15.73% | -19.78% | -41.59% | - | - | - | - | 7.06B | |
| Average | +2.23% | -0.71% | -4.80% | +2.47% | +13.26% | +48.92% | +134.90% | +111.11% | +1,084.60% | 15.01B | |
| Weighted average by Cap. | +1.99% | +0.27% | -2.69% | +5.64% | +8.07% | +45.91% | +124.81% | +111.68% | +2,811.63% |
- Stock Market
- Stocks
- TNG Stock
- Sector Transgene
Select your edition
All financial news and data tailored to specific country editions
